General Information of This Metabolic Reaction (MR) (ID: MR002569)
Formula Reactant Cabazitaxel metabolite M07 Product Cabazitaxel metabolite M08b
Reactant Info Product Info
Metabolic Type Oxidation - Hydroxylation
Other MR(s) Related to The Reactant of This MR
Other MR(s) That Produce The Reactant of This MR
MR ID Reactant Product MR Type Related Drug REF
MR002567 RPR112698 Cabazitaxel metabolite M07 Oxidation - Hydroxylation Cabazitaxel [1]
Other MR(s) That Metabolize The Reactant of This MR
MR ID Reactant Product MR Type Related Drug REF
MR002568 Cabazitaxel metabolite M07 RPR104952 Oxidation - 10-O-Demethylation Cabazitaxel [1]
Other MR(s) Related to The Product of This MR
Other MR(s) That Produce The Product of This MR
MR ID Reactant Product MR Type Related Drug REF
MR002574 Cabazitaxel metabolite M2 Cabazitaxel metabolite M08b Oxidation - Cleavage Cabazitaxel [1]
Other MR(s) That Metabolize The Produtc of This MR
MR ID Reactant Product MR Type Related Drug REF
MR002571 Cabazitaxel metabolite M08b Cabazitaxel metabolite M02a Oxidation - Hydroxylation Cabazitaxel [1]
MR002570 Cabazitaxel metabolite M08b RPR111026 Oxidation - 10-O-Demethylation Cabazitaxel [1]
References
1 A phase I open-label study investigating the disposition of [14C]-cabazitaxel in patients with advanced solid tumors Anticancer Drugs. 2015 Mar;26(3):350-8. doi: 10.1097/CAD.0000000000000185.

If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.